Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Juzentaihoto for Late Onset Hypogonadism
jRCT1061200053Completed
- Start
- May 2021
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of juzentaihoto in late-onset hypogonadism (LOH). Started May 2021; status: completed.
02
Drugs
juzentaihoto
03
Conditions
late-onset hypogonadism (LOH)
Beyond the preview
Go deeper on jRCT1061200053.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1061200053.